Novartis subsidiary Sandoz launched a generic challenger to AbbVie’s Combigan on Thursday. The debut came less than two weeks after the FDA approved the generic ophthalmic solution. Its arrival marks ...

Glenmark has received the Food and Drug Administration’s permission for brimonidine tartrate and timolol maleate ophthalmic solution, 0.2%|0.5%, which is the ...